References
- Cui MF, Chen LM, Jiang C, Ma BZ, Yuan FW, Zhao C, et al. Risks associated with cognitive function and management strategies in the clinical use of ADT: a systematic review from clinical and preclinical studies. Support Care Cancer. 2024 Jul 31;32(8):561.
- Mirzaei A, Deyhimfar R, Azodian Ghajar H, Mashhadi R, Noori M, Dialameh H, et al. Quercetin can be a more reliable treatment for metastatic prostate cancer than the localized disease: An in vitro study. J Cell Mol Med. 2023 May 26;27(12):1725–34.
- Yang X, Chen H, Xu D, Chen X, Li Y, Tian J, et al. Efficacy and safety of Androgen Deprivation Therapy (ADT) combined with modified docetaxel chemotherapy versus ADT combined with standard docetaxel chemotherapy in patients with metastatic castration-resistant prostate cancer: study protocol for a multicentre prospective randomized controlled trial. BMC Cancer. 2022 Feb 16;22:177.
- Zhang B, Yao K, Cheng C. A network-based integration for understanding racial disparity in prostate cancer. Transl Oncol. 2022 Jan 5;17:101327.
- Bégay V, Cirovic B, Barker AJ, Klopfleisch R, Hart DW, Bennett NC, et al. Immune competence and spleen size scale with colony status in the naked mole-rat. Open Biol. 12(4):210292.
- Licitra F, Giovannelli P, Di Donato M, Monaco A, Galasso G, Migliaccio A, et al. New Insights and Emerging Therapeutic Approaches in Prostate Cancer. Front Endocrinol (Lausanne). 2022 Feb 11;13:840787.
- Rupp NJ, Freiberger SN, Ferraro DA, Laudicella R, Heimer J, Muehlematter UJ, et al. Immunohistochemical ERG positivity is associated with decreased PSMA expression and lower visibility in corresponding [68Ga]Ga-PSMA-11 PET scans of primary prostate cancer. Eur J Nucl Med Mol Imaging. 2024 Jul 31;
- Gan J, Zeng X, Wang X, Wu Y, Lei P, Wang Z, et al. Effective Diagnosis of Prostate Cancer Based on mRNAs From Urinary Exosomes. Front Med (Lausanne). 2022 Mar 23;9:736110.
- Cheng HH, Shevach JW, Castro E, Couch FJ, Domchek SM, Eeles RA, et al. BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review. JAMA Oncol. 2024 Jul 25;
- Golubnitschaja O, Kubatka P, Mazurakova A, Samec M, Alajati A, Giordano FA, et al. Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper. Cancers (Basel). 2022 Jan 28;14(3):675.
- Nzombe L, Shirinde J, Patrick S. Insights into prostate cancer awareness and perceptions among men in Tshwane. S Afr Med J. 2024 Jun 24;114(6b):e1307.
- Pandit AA, Patil NN, Mostafa M, Kamel M, Halpern MT, Li C. Rural–Urban Disparities in Patient Care Experiences among Prostate Cancer Survivors: A SEER-CAHPS Study. Cancers (Basel). 2023 Mar 23;15(7):1939.
- Rangel-Pozzo A, Liu S, Wajnberg G, Wang X, Ouellette RJ, Hicks GG, et al. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level. Cells. 2020 Aug 8;9(8):1863.
- Sun H, Sun R, Song X, Gu W, Shao Y. Mechanism and clinical value of exosomes and exosomal contents in regulating solid tumor radiosensitivity. J Transl Med. 2022 Apr 28;20:189.
- Cheng YT, Huang CY, Chen CH, Chiu ST, Hong JH, Pu YS, et al. Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical Prostatectomy. Sci Rep. 2020 Jan 21;10:776.
- Zeng YY, Gu Q, Li D, Li AX, Liu RM, Liang JY, et al. Immunocyte membrane-derived biomimetic nano-drug delivery system: a pioneering platform for tumour immunotherapy. Acta Pharmacol Sin. 2024 Jul 31;
- Han Y, Zou C, Liu T, Cheng W, Cheng P, Wu A. Inhibiting interferon-γ induced cancer intrinsic TNFRSF14 elevation restrains the malignant progression of glioblastoma. J Exp Clin Cancer Res. 2024 Jul 31;43(1):212.
- Cari L, Sorrentino R, Akkaya B, Nocentini G. Editorial: Targeting regulatory cells in cancer: old and new approaches in immunotherapy. Front Immunol. 2024;15:1458280.
- Wang HC, Xia R, Chang WH, Hsu SW, Wu CT, Chen CH, et al. Improving cancer immunotherapy in prostate cancer by modulating T cell function through targeting the galectin-1. Front Immunol. 2024;15:1372956.
- Somoza-Fernández B, Escudero-Vilaplana V, Collado-Borrell R, Pérez-Ramírez S, Villanueva-Bueno C, Montero-Antón MDP, et al. Severe neutropenia probably caused by enzalutamide and abiraterone in a prostate cancer patient. J Oncol Pharm Pract. 2024 Jul 23;10781552241264530.
- Al-Janabi H, Moyes K, Allen R, Fisher M, Crespo M, Gurel B, et al. Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy. J Immunother Cancer. 2024 Jul 25;12(7):e009368.
- Lafta HA, AbdulHussein AH, Al-Shalah SAJ, Alnassar YS, Mohammed NM, Akram SM, et al. Tumor-associated Macrophages (TAMs) in Cancer Resistance; Modulation by Natural Products. Curr Top Med Chem. 2023;23(12):1104–22.
- Ahluwalia P, Mondal AK, Sahajpal NS, Rojiani MV, Kolhe R. Gene signatures with therapeutic value: emerging perspective for personalized immunotherapy in renal cancer. Immunotherapy. 2021 Dec;13(18):1535–47.
- Sathish G, Monavarshini LK, Sundaram K, Subramanian S, Kannayiram G. Immunotherapy for lung cancer. Pathol Res Pract. 2024 Feb;254:155104.
- Albittar AA, Alhalabi O, Glitza Oliva IC. Immunotherapy for Melanoma. Adv Exp Med Biol. 2020;1244:51–68.
- Wang Y, Su H, Lu Y, Li H. Regulatory Role of Fatty Acid Metabolism-Related Long Noncoding RNA in Prostate Cancer: A Computational Biology Study Analysis. J Oncol. 2023 Feb 14;2023:9736073.
- Xu M, Zheng J, Hou T, Lin H, Wang T, Wang S, et al. SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study. Diabetes Care. 2022 Nov;45(11):2718–28.
- Saw J, Yang ML, Trinder M, Tcheandjieu C, Xu C, Starovoytov A, et al. Chromosome 1q21.2 and additional loci influence risk of spontaneous coronary artery dissection and myocardial infarction. Nat Commun. 2020 Sep 4;11:4432.
- Zhang Y, Ou D hua, Zhuang D wu, Zheng Z feng, Lin M en. In silico analysis of the immune microenvironment in bladder cancer. BMC Cancer. 2020 Mar 30;20:265.
- Lu X, Li R, Ying Y, Zhang W, Wang W. Gene signatures, immune infiltration, and drug sensitivity based on a comprehensive analysis of m6a RNA methylation regulators in cervical cancer. J Transl Med. 2022 Sep 4;20:385.
- Cui S, Zhang M, Bai S, Bi Y, Cong S, Jin S, et al. Development of Prognostic Features of Hepatocellular Carcinoma Based on Metabolic Gene Classification and Immune and Oxidative Stress Characteristic Analysis. Oxid Med Cell Longev. 2023 Feb 18;2023:1847700.
- Zhao S, Chi H, Yang Q, Chen S, Wu C, Lai G, et al. Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson's disease. Front Immunol. 2023 Feb 7;14:1090040.
- Chen L, Zhang K, Sun J, Tang J, Zhou J. Development and Validation of an Autophagy-Stroma-Based Microenvironment Gene Signature for Risk Stratification in Colorectal Cancer. Onco Targets Ther. 2021 May 31;14:3503–15.
- Zhang G, Lu J, Zheng J, Mei S, Li H, Zhang X, et al. Spi1 regulates the microglial/macrophage inflammatory response via the PI3K/AKT/mTOR signaling pathway after intracerebral hemorrhage. Neural Regen Res. 2023 May 31;19(1):161–70.
- Li W, Huang W, Li P, Wen Y, Shuai T, He Y, et al. Application of deep learning image reconstruction-high algorithm in one-stop coronary and carotid-cerebrovascular CT angiography with low radiation and contrast doses. Quant Imaging Med Surg. 2024 Feb 1;14(2):1860–72.
- Shen Z, Zhao Z, Ren Q, Yan M. Female Off-Farm Employment and Fertility Timing in Rural China. Front Public Health. 2022 Mar 31;10:790436.
- O'Farrell F, Jiang X, Aljifri S, Pazoki R. Molecular Alterations Caused by Alcohol Consumption in the UK Biobank: A Mendelian Randomisation Study. Nutrients. 2022 Jul 19;14(14):2943.
- Yuan J, Xiong X, Zhang B, Feng Q, Zhang J, Wang W, et al. Genetically predicted C-reactive protein mediates the association between rheumatoid arthritis and atlantoaxial subluxation. Front Endocrinol (Lausanne). 2022 Dec 16;13:1054206.
- Marshall EA, Ng KW, Kung SHY, Conway EM, Martinez VD, Halvorsen EC, et al. Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis. Mol Cancer. 2016 Oct 27;15:67.
- Sadeqi Nezhad M, Seifalian A, Bagheri N, Yaghoubi S, Karimi MH, Adbollahpour-Alitappeh M. Chimeric Antigen Receptor Based Therapy as a Potential Approach in Autoimmune Diseases: How Close Are We to the Treatment? Front Immunol. 2020 Nov 26;11:603237.
- Du X, Zhou Z, Shao Y, Qian K, Wu Y, Zhang J, et al. Immunoarchitectural patterns as potential prognostic factors for invasive ductal breast cancer. NPJ Breast Cancer. 2022 Feb 28;8:26.
- Jin Z, Wang M, Meng Y, Chen D, Xu Y, Jiang X, et al. Prognostic Implication of a Cuproptosis-Related miRNA Signature in Hepatocellular Carcinoma. J Healthc Eng. 2022 Sep 13;2022:4694323.
- Franzolin G, Brundu S, Cojocaru CF, Curatolo A, Ponzo M, Mastrantonio R, et al. PlexinB1 inactivation reprograms immune cells in the tumor microenvironment, inhibiting breast cancer growth and metastatic dissemination. Cancer Immunol Res. 2024 Jun 14;
- Huang H, Li L, Luo W, Yang Y, Ni Y, Song T, et al. Lymphocyte percentage as a valuable predictor of prognosis in lung cancer. J Cell Mol Med. 2022 Apr;26(7):1918–31.
- Simon M, Stüve P, Schmidleithner L, Bittner S, Beumer N, Strieder N, et al. Single-cell chromatin accessibility and transposable element landscapes reveal shared features of tissue-residing immune cells. Immunity. 2024 Jul 17;S1074-7613(24)00321-2.
- He J, Chen Z, Xue Q, Sun P, Wang Y, Zhu C, et al. Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature. J Transl Med. 2022 Apr 25;20:186.
- Khalid K, Ahsan O, Khaliq T, Muhammad K, Waheed Y. Immunoinformatics-Based Proteome Mining to Develop a Next-Generation Vaccine Design against Borrelia burgdorferi: The Cause of Lyme Borreliosis. Vaccines (Basel). 2022 Aug 2;10(8):1239.
- Qin W, Gan F, Jike Y, Jiang M, Li A. Consensus Clustering and Survival-Related Genes of Cuproptosis in Cutaneous Melanoma. Mediators Inflamm. 2023 Feb 27;2023:3615688.
- Fan X, Men R, Huang C, Shen M, Wang T, Ghnewa Y, et al. Critical roles of conventional dendritic cells in autoimmune hepatitis via autophagy regulation. Cell Death Dis. 2020 Jan 13;11(1):23.
- Paul S, Chhatar S, Mishra A, Lal G. Natural killer T cell activation increases iNOS+CD206- M1 macrophage and controls the growth of solid tumor. J Immunother Cancer. 2019 Aug 6;7:208.